Literature DB >> 20620447

Islet transplantation: lessons learned since the Edmonton breakthrough.

R M Langer1.   

Abstract

This work sought to summarize the main issues of the last decade in the field of clinical islet transplantation. Ten years ago in Edmonton, a new protocol initiated for islet transplantation brought a breakthrough to the field. The earlier, rather poor results were in a sharp contrast to the first published results of 100% insulin freedom at 1 year. However, later it became clear that the promising initial results decline with time; at around 5 years, only about 10% of the patients maintain freedom from external insulin. Despite that fact, a milestone was set and intensive research started worldwide. New hopes were raised for patients. Modifications of the original protocol have been implemented to improve clinical results; however, islet transplantation remains an experimental procedure to date.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620447     DOI: 10.1016/j.transproceed.2010.04.021

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  13 in total

Review 1.  Recent progress in pancreatic islet transplantation.

Authors:  Takashi Kuise; Hirofumi Noguchi
Journal:  World J Transplant       Date:  2011-12-24

Review 2.  Islet and stem cell encapsulation for clinical transplantation.

Authors:  Rahul Krishnan; Michael Alexander; Lourdes Robles; Clarence E Foster; Jonathan R T Lakey
Journal:  Rev Diabet Stud       Date:  2014-05-10

3.  Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer.

Authors:  Jumpei Kondo; Hiroko Endo; Hiroaki Okuyama; Osamu Ishikawa; Hiroyasu Iishi; Masahiko Tsujii; Masayuki Ohue; Masahiro Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

4.  Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice.

Authors:  C L Rackham; P C Chagastelles; N B Nardi; A C Hauge-Evans; P M Jones; A J F King
Journal:  Diabetologia       Date:  2011-01-26       Impact factor: 10.122

Review 5.  Integration of Islet/Beta-Cell Transplants with Host Tissue Using Biomaterial Platforms.

Authors:  Daniel W Clough; Jessica L King; Feiran Li; Lonnie D Shea
Journal:  Endocrinology       Date:  2020-11-01       Impact factor: 4.736

6.  Regulation of the CCL2 gene in pancreatic β-cells by IL-1β and glucocorticoids: role of MKP-1.

Authors:  Susan J Burke; Matthew R Goff; Barrett L Updegraff; Danhong Lu; Patricia L Brown; Steven C Minkin; John P Biggerstaff; Ling Zhao; Michael D Karlstad; J Jason Collier
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.

Authors:  Preeti Chhabra; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-20

Review 8.  Stem cell biology and drug discovery.

Authors:  Lee L Rubin; Kelly M Haston
Journal:  BMC Biol       Date:  2011-06-07       Impact factor: 7.431

Review 9.  Modulating the foreign body response of implants for diabetes treatment.

Authors:  Bhushan N Kharbikar; Gauree S Chendke; Tejal A Desai
Journal:  Adv Drug Deliv Rev       Date:  2021-01-21       Impact factor: 17.873

10.  Controlled aggregation of primary human pancreatic islet cells leads to glucose-responsive pseudoislets comparable to native islets.

Authors:  Janneke Hilderink; Siebe Spijker; Françoise Carlotti; Lydia Lange; Marten Engelse; Clemens van Blitterswijk; Eelco de Koning; Marcel Karperien; Aart van Apeldoorn
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.